|
|
[½»Á÷]
Tet-on±í´ïµ÷¿ØÏµÍ³
1992ÄêGoseenµÈÈ˳ɹ¦µÄÀûÓÃԺ˻ùÒòµ÷¿ØÔª¼þ¹¹½¨ÁËËÄ»·ËØ£¨tetracycline,Tet£©ÕæºËϸ°û»ùÒòµ÷¿Ø±í´ïϵͳ¡£Ä¿Ç°£¬´ËϵͳÒѱ»¹ã·ºÓ¦ÓÃÓÚ»ùÒò¹¦ÄܺͻùÒòÖÎÁÆÁìÓòµÄÑо¿¡£
1¡¢ËÄ»·Ëص÷¿Ø±í´ïϵͳµÄ»ù±¾ÔÀí
Tetµ÷¿Ø±í´ïϵͳͨ¹ýÓÕµ¼Ò©ÎÈçTet£©¸Ä±äµ÷¿Øµ°°×µÄ¹¹Ï󣬴Ӷø´ïµ½µ÷¿ØÄ¿±êµ°°×±í´ïµÄÄ¿µÄ¡£
×î³õµÄTetµ÷¿Ø»ùÒò±í´ïϵͳÊÇÒԴ󳦸˾úTn10ת×ù×ÓÉÏTet¿¹ÐÔ²Ù×Ý×ÓΪ»ù´¡¶ø½¨Á¢µÄ¡£Tet×è¶ôµ°°×£¨Tet repressor protein, TetR£©ÓëTet²Ù×Ý×Ó£¨Tet operator, TetO£©Äܹ»ÌØÒìÐÔ½áºÏ¡£µ±Ï¸°ûÄÚÎÞTet´æÔÚʱ£¬Tet»áÓëTetO½áºÏ£¬´Ó¶ø×è¶ÏÏÂÓο¹ÐÔ»ùÒò±í´ï£»µ±ÓÐTet´æÔÚʱ£¬TetʹTetR¹¹Ïó·¢Éú¸Ä±ä£¬µ¼ÖÂTetRÓëTetO·ÖÀ룬ʹÏÂÓο¹ÐÔ»ùÒòµÃÒÔ±í´ï£¬Ï¸¾ú´Ó¶ø»ñµÃÄÍÒ©ÐÔ

2¡¢Tet-onµ÷¿ØÏµÍ³
ÀûÓÃTetRºÍTetOÌØÒìÐÔ½áºÏµÄÌØµã£¬¶àÖÖÀàÐ͵ÄTetµ÷¿ØÏµÍ³Öð½¥·¢Õ¹ÆðÀ´¡£¸ù¾ÝÓ¦ÓÃ×îΪ¹ã·ºµÄÊÇTet-on¼¤»îÐÍϵͳ¡£
Tet-onϵͳÓɵ÷½Ú±í´ïÔØÌåºÍ·´Ó¦±í´ïÔØÌå×é³É¡£
µ÷½Ú±í´ïÔØÌå°üº¬Ò»¸öÈ˾Þϸ°û²¡¶¾ÔçÆÚÆô¶¯×Ó£¨PhCMV£©ºÍ·´ÒåTetת¼»î»¯Òò×Ó£¨reverse tetracycline transcriptional activator£¬rtTA£©¡£ÆäÖÐrtTAÓÉ·´ÒåTetR£¨reverse TetR, rTetR£©ºÍµ¥´¿ðåÕ¶¾£¨HSV£©VP16µ°°×C¶ËµÄÒ»¶Îת¼¼¤»îÇøÓòÈں϶ø³É¡£
·´Ó¦±í´ïÔØÌåÓÉTetÓ¦´ðÔª¼þ£¨Tet-responsive element, TRE£©¡¢×îСCMVÆô¶¯×Ó£¨minimal CMV promoter, PminCMV£©¼°Ä¿µÄ»ùÒò×é³É¡£ÆäÖÐTREÊÇ7¸öÖØ¸´µÄTetOÐòÁС£
ÓÉÓÚPminCMVȱÉÙÔöÇ¿×Ó£¬Òò´ËrtTAδÓëTRE½áºÏʱ£¬Ä¿µÄ»ùÒò²»±í´ï£»µ±rtTAÓëTRE½áºÏʱ£¬VP16»áʹPminCMV»î»¯´Ó¶øÊ¹»ùÒò±í´ï¡£
ÔÚDox²»´æÔÚʱ£¬rTetR²»ÄÜÓëTRE½áºÏ£¬µ¼Ö»ùÒò±í´ï±»ÒÖÖÆ£»¶øµ±Dox´æÔÚʱ£¬rTetRÄÜÓëTRE½áºÏ£¬½ø¶øÊ¹µÃÄ¿µÄ»ùÒò±í´ï¡£

3¡¢Tet-onµ÷¿ØÏµÍ³µÄÓÅÊÆ
Tet-onµ÷¿ØÏµÍ³¼¯¸ßЧÂÊ¡¢¾«×¼¡¢°²È«¡¢¿ÉÄæÐÔËÄ´óÌØµã¡£
Î¬Õæ¿ÉΪÄúÌṩÏÙ²¡¶¾¡¢Âý²¡¶¾¡¢ÏÙÏà¹Ø²¡¶¾ºÍËÄ»·Ëص÷¿Ø±í´ïÔØÌ壬»¹Ìṩ²¡¶¾°ü×°·þÎñ¡£

|
|